SCHEMBL7974302

SCHEMBL7974302

NCCc1nc2ncn(Cc3ccc(F)cc3)c2c(=O)[nH]1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.45
ALDH1A1 P00352 3/20 0.45
KMT2A Q03164 2/20 0.44
HPGD P15428 2/20 0.43
TYMS P04818 1/20 0.40
HTT P42858 1/20 0.39
HCAR2 Q8TDS4 1/20 0.38
BRD4 O60885 2/20 0.38
IDO1 P14902 1/20 0.38
MET P08581 1/20 0.38
KDM4E B2RXH2 1/20 0.37
CYP11B2 P19099 1/20 0.37
BRDT Q58F21 1/20 0.36
POLB P06746 1/20 0.36
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7975136 0.88 HPGD (0.45) SMN1; SMN2ALDH1A1KMT2AHPGDHTT
SCHEMBL7988953 0.88 HPGD (0.45) SMN1; SMN2ALDH1A1KMT2AHPGDTYMS
SCHEMBL7985634 0.88 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1KMT2AHPGDHCAR2
Hydrochloric Acid SCHEMBL7987615 0.87 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1KMT2AHPGDHCAR2
SCHEMBL7988531 0.87 ALDH1A1 (0.44) SMN1; SMN2ALDH1A1KMT2AHPGDHCAR2
SCHEMBL7984524 0.86 HPGD (0.52) SMN1; SMN2ALDH1A1KMT2AHPGDTYMS
SCHEMBL7985636 0.85 ABCC8 (0.47) SMN1; SMN2ALDH1A1KMT2AHPGDBRD4
SCHEMBL7985510 0.83 HPGD (0.47) SMN1; SMN2ALDH1A1KMT2AHPGDTYMS
SCHEMBL7974294 0.83 HPGD (0.43) SMN1; SMN2ALDH1A1KMT2AHPGDHCAR2
SCHEMBL7988672 0.82 SMN1; SMN2 (0.47) SMN1; SMN2ALDH1A1KMT2AHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed